Komaba, Hirotaka
Ketteler, Markus
Cunningham, John
Fukagawa, Masafumi http://orcid.org/0000-0002-7832-2339
Article History
Received: 3 November 2020
Accepted: 4 December 2020
First Online: 2 January 2021
Compliance with Ethical Standards
:
: Hirotaka Komaba has received honoraria, consulting fees, and/or grant support from Bayer Yakuhin, Chugai Pharmaceutical, Japan Tobacco, Kyowa Kirin, Novartis, and Ono Pharmaceutical. Markus Ketteler has received honoraria for consulting and lecture fees from Amgen, Bayer, Kyowa Kirin, Medice, Ono Pharmaceutical, Sanofi, and Vifor Pharma. John Cunningham has receive honoraria, consulting fees, and/or grant support from Vifor Pharma, Amgen, Merck, and Opko Pharma. Masafumi Fukagawa has received honoraria, consulting fees, and/or grant support from Bayer Yakuhin, Fresenius Kabi, Kissei Pharmaceutical, Kyowa Kirin, Ono Pharmaceutical, and Torii Pharmaceutical.